BR112013028406A2 - método para identificar alvos de antibióticos - Google Patents

método para identificar alvos de antibióticos

Info

Publication number
BR112013028406A2
BR112013028406A2 BR112013028406A BR112013028406A BR112013028406A2 BR 112013028406 A2 BR112013028406 A2 BR 112013028406A2 BR 112013028406 A BR112013028406 A BR 112013028406A BR 112013028406 A BR112013028406 A BR 112013028406A BR 112013028406 A2 BR112013028406 A2 BR 112013028406A2
Authority
BR
Brazil
Prior art keywords
antibiotic targets
identifying antibiotic
identifying
targets
antibiotic
Prior art date
Application number
BR112013028406A
Other languages
English (en)
Other versions
BR112013028406B1 (pt
BR112013028406B8 (pt
Inventor
Arthur Keith Turner
David Hugh Williams
Original Assignee
Discuva Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Discuva Ltd filed Critical Discuva Ltd
Publication of BR112013028406A2 publication Critical patent/BR112013028406A2/pt
Publication of BR112013028406B1 publication Critical patent/BR112013028406B1/pt
Publication of BR112013028406B8 publication Critical patent/BR112013028406B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1082Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/06Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50Mutagenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biochemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112013028406A 2011-05-05 2012-05-03 Método para identificar alvos de antibióticos BR112013028406B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB11075150.7 2011-05-05
GBGB1107515.7A GB201107515D0 (en) 2011-05-05 2011-05-05 Method for identifying antibiotic targets
PCT/GB2012/000402 WO2012150432A1 (en) 2011-05-05 2012-05-03 Method for identifying antibiotic targets

Publications (3)

Publication Number Publication Date
BR112013028406A2 true BR112013028406A2 (pt) 2016-09-20
BR112013028406B1 BR112013028406B1 (pt) 2021-12-07
BR112013028406B8 BR112013028406B8 (pt) 2022-03-03

Family

ID=44243664

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013028406A BR112013028406B8 (pt) 2011-05-05 2012-05-03 Método para identificar alvos de antibióticos

Country Status (15)

Country Link
US (2) US9745572B2 (pt)
EP (1) EP2705148B1 (pt)
JP (1) JP6015974B2 (pt)
KR (1) KR101984324B1 (pt)
CN (1) CN103687948B (pt)
AU (1) AU2012251521B2 (pt)
BR (1) BR112013028406B8 (pt)
CA (1) CA2835133C (pt)
DK (1) DK2705148T5 (pt)
ES (1) ES2618207T3 (pt)
GB (1) GB201107515D0 (pt)
PT (1) PT2705148T (pt)
RU (1) RU2630622C2 (pt)
SG (1) SG194777A1 (pt)
WO (1) WO2012150432A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201107516D0 (en) 2011-05-05 2011-06-22 Discuva Ltd Method for identifying antibiotic targets by complemented sequencing
GB201107515D0 (en) 2011-05-05 2011-06-22 Discuva Ltd Method for identifying antibiotic targets
GB201219989D0 (en) * 2012-11-06 2012-12-19 Discuva Ltd Bacterial engineering
GB201413198D0 (en) 2014-07-25 2014-09-10 Discuva Ltd Methods For Characterizing Bacterial Mutants
GB201507931D0 (en) 2015-05-08 2015-06-24 Discuva Ltd Combination therapies for combating resistance
US10629291B2 (en) * 2016-03-10 2020-04-21 Koninklijke Philips N.V. Antibiotic resistance causation identification

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2241758C2 (ru) * 1994-12-09 2004-12-10 Империал Колледж Инновейшенс Лимитед, Майкросайенс Лимитед Способ определения микроорганизма с пониженной адаптацией к конкретной окружающей среде, днк (варианты), ген вирулентности, полипептид, способ определения соединения, антисмысловая нуклеиновая кислота, способ лечения хозяина и фармацевтическая композиция
IL121996A0 (en) * 1997-10-19 1998-03-10 Rosenberg Peretz Drip irrigation devices and method of making same
US6207384B1 (en) * 1998-03-27 2001-03-27 The General Hospital Corporation Systematic identification of essential genes by in vitro transposon mutagenesis
GB9917531D0 (en) 1999-07-26 1999-09-29 Arrow Therapeutics Ltd Transposon mediated differential hybridisation
US6991900B2 (en) 2000-06-28 2006-01-31 California Institute Of Technology Methods for identifying an essential gene in a prokaryotic microorganism
US20020076722A1 (en) * 2000-09-13 2002-06-20 Neyfakh Alexander A. Antibiotic hypersusceptibility mutations in bacteria
KR100459870B1 (ko) 2002-02-22 2004-12-04 한국과학기술원 트랜스포존과 Cre/loxP 부위 특이적 재조합 방법을 이용하는 염색체의 특정부위가 제거된 미생물 변이주 제조방법
AU2003278714A1 (en) 2002-08-20 2004-03-11 Chiron Corporation Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
US20100247495A1 (en) 2009-03-30 2010-09-30 Tom Ichim Treatment of Muscular Dystrophy
GB201107515D0 (en) 2011-05-05 2011-06-22 Discuva Ltd Method for identifying antibiotic targets
GB201107516D0 (en) 2011-05-05 2011-06-22 Discuva Ltd Method for identifying antibiotic targets by complemented sequencing
GB201219989D0 (en) 2012-11-06 2012-12-19 Discuva Ltd Bacterial engineering
US20160201129A1 (en) 2013-08-26 2016-07-14 President And Fellows Of Harvard College Determination of immune cells and other cells
GB2505819B (en) 2013-12-13 2014-10-01 Discuva Ltd Method for identifying genes involved in antibiotic resistance and sensitivity in gram-negative bacteria
GB201413202D0 (en) 2014-07-25 2014-09-10 Discuva Ltd Process for producing bacterial mutants
GB201413198D0 (en) 2014-07-25 2014-09-10 Discuva Ltd Methods For Characterizing Bacterial Mutants
GB201421854D0 (en) 2014-12-09 2015-01-21 Discuva Ltd Identifying genes involved in antibiotic resistance and sensitivity in bacteria using microcultures
GB201421850D0 (en) 2014-12-09 2015-01-21 Bactevo Ltd Method for screening for bioactive natural products

Also Published As

Publication number Publication date
BR112013028406B1 (pt) 2021-12-07
KR20140057207A (ko) 2014-05-12
US20180010122A1 (en) 2018-01-11
ES2618207T3 (es) 2017-06-21
AU2012251521B2 (en) 2016-07-14
RU2630622C2 (ru) 2017-09-11
CN103687948B (zh) 2018-12-04
WO2012150432A1 (en) 2012-11-08
GB201107515D0 (en) 2011-06-22
EP2705148B1 (en) 2016-11-23
CA2835133A1 (en) 2012-11-08
US20220186211A9 (en) 2022-06-16
EP2705148A1 (en) 2014-03-12
CN103687948A (zh) 2014-03-26
KR101984324B1 (ko) 2019-05-30
US20140141979A1 (en) 2014-05-22
DK2705148T5 (en) 2017-03-13
JP2014513961A (ja) 2014-06-19
PT2705148T (pt) 2017-03-02
DK2705148T3 (en) 2017-02-13
BR112013028406B8 (pt) 2022-03-03
WO2012150432A8 (en) 2013-01-03
US11359195B2 (en) 2022-06-14
CA2835133C (en) 2020-05-05
JP6015974B2 (ja) 2016-10-26
US9745572B2 (en) 2017-08-29
AU2012251521A1 (en) 2013-11-21
SG194777A1 (en) 2013-12-30
RU2013149303A (ru) 2015-06-10

Similar Documents

Publication Publication Date Title
CO6950446A2 (es) Mecanismo y método de sellado para empalme de cable de bajada
BR112014005087A2 (pt) método para detectar nucleossomas contendo nucleotídeos
DE102012208877A8 (de) System zur Erfassung bewegter Objekte
CO6910200A2 (es) Derivado de pirazoloquinolina
BR112013014703A2 (pt) mapeamento de informação eficiente para concessões de transmissão
BR112014002252A2 (pt) métodos para a detecção de modificação de nucleotídeo
BR112014000451A2 (pt) sistemas e métodos para determinar coberturas opcionais de seguro
BR112014007958A2 (pt) método
CL2015000158A1 (es) Metodo para la manipulacion de aguacates
BR112014001237A2 (pt) método
BR112014001765A2 (pt) método
BR112013030423A2 (pt) método para produção de biocoque
CO6920298A2 (es) Método para cultivar caña de azucar
EP2691542A4 (en) SCREENING METHODS FOR IDENTIFICATION OF SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS
CU24164B1 (es) Inhibidores sustituidos de acetil-coa carboxilasa
EP2678319A4 (en) ANTIBIOTICS TOLERANCE INHIBITORS
BR112014016066A2 (pt) método para detectar micro-organismos salmonella
BR112014009795A2 (pt) método
BR112015005752A2 (pt) método para fabricação de cilindros de gás
BR112012021070A2 (pt) método para produção de cadaverina
FR2969276B1 (fr) Machine de lancement de cibles
BR112013028406A2 (pt) método para identificar alvos de antibióticos
BR112014007794A2 (pt) método para otimização de desempenho de solda
BR112014012534A2 (pt) métodos para a preparação de hidrogéis
PT2705149T (pt) Método de identificação de alvos de antibióticos por sequenciamento complementar

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2614 DE 09/02/2021 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: PARECER DE DEFERIMENTO COM INCORRECAO NO QUADRO 1 DO PARECER.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/05/2012, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2657 DE 07/12/2021 QUANTO AO QUADRO REIVINDICATORIO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2721 DE 28-02-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.